Use the base editing function of CRISPR system to reduce the transcription and protein expression of TERT, and induce the aging and proliferation stagnation of cancer cells, which verifies the feasibility of activated TERT promoter mutation as a cancer-specific therapeutic target (Killela et al., 2013; Li et al., 2020). This evidence concerns the gene TERT and cancer.